Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
BACKGROUND: Currently, population pharmacokinetic (PK) studies of anti-malarial drugs are designed primarily by the logistical and ethical constraints of taking blood samples from patients, and the statistical models that are fitted to the data are not formally considered. This could lead to impreci...
主要な著者: | Jamsen, K, Duffull, S, Tarning, J, Lindegardh, N, White, N, Simpson, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
BioMed Central
2011
|
類似資料
-
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
著者:: Lindegardh Niklas, 等
出版事項: (2011-07-01) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria.
著者:: Jamsen, K, 等
出版事項: (2012) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
著者:: Jamsen Kris M, 等
出版事項: (2012-07-01) -
Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
著者:: Tarning, J, 等
出版事項: (2012) -
Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
著者:: Tarning, J, 等
出版事項: (2012)